These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31961408)

  • 1. Trends in Buprenorphine Treatment in the United States, 2009-2018.
    Olfson M; Zhang VS; Schoenbaum M; King M
    JAMA; 2020 Jan; 323(3):276-277. PubMed ID: 31961408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine Dispensing after Elimination of the Waiver Requirement.
    Chua KP; Bicket MC; Bohnert ASB; Conti RM; Lagisetty P; Nguyen TD
    N Engl J Med; 2024 Apr; 390(16):1530-1532. PubMed ID: 38657250
    [No Abstract]   [Full Text] [Related]  

  • 3. US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011-2016.
    Shastry S; Manini AF; Richardson LD; Lin MP
    J Gen Intern Med; 2020 Mar; 35(3):965-966. PubMed ID: 31414352
    [No Abstract]   [Full Text] [Related]  

  • 4. National- and State-Level Pharmacy-Based Buprenorphine Dispensing, United States 2019-2021.
    Barham CL; Strahan AE; Zhang K; Guy GP
    J Gen Intern Med; 2024 Aug; 39(10):1951-1953. PubMed ID: 38806799
    [No Abstract]   [Full Text] [Related]  

  • 5. The Number Needed to Prescribe - What Would It Take to Expand Access to Buprenorphine?
    Poorman E
    N Engl J Med; 2021 May; 384(19):1783-1784. PubMed ID: 33983689
    [No Abstract]   [Full Text] [Related]  

  • 6. Why 24 State and Territorial Health Officials Support Buprenorphine Deregulation.
    Stancliff S; Greene D; Zucker HA
    Am J Public Health; 2019 Dec; 109(12):1678-1679. PubMed ID: 31693402
    [No Abstract]   [Full Text] [Related]  

  • 7. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.
    Sigmon SC; Bigelow GE
    Addiction; 2017 Mar; 112(3):386-387. PubMed ID: 27561982
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.
    McBain RK; Dick A; Sorbero M; Stein BD
    Ann Intern Med; 2020 Apr; 172(7):504-506. PubMed ID: 31905379
    [No Abstract]   [Full Text] [Related]  

  • 9. A New Way Forward in the Emergency Department.
    Schwarz ES; Laes JR; Wiegand TJ
    J Med Toxicol; 2019 Oct; 15(4):220-222. PubMed ID: 31278586
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of Buprenorphine to Treat Opioid Use Disorder.
    Bartholow LAM; Pope J
    J Psychosoc Nurs Ment Health Serv; 2018 Nov; 56(11):9-12. PubMed ID: 30383881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
    Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
    JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series.
    Suzuki J; DeVido J; Kalra I; Mittal L; Shah S; Zinser J; Weiss RD
    Am J Addict; 2015 Jan; 24(1):10-4. PubMed ID: 25823630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
    Chou R; Ballantyne J; Lembke A
    Ann Intern Med; 2019 Sep; 171(6):427-429. PubMed ID: 31450240
    [No Abstract]   [Full Text] [Related]  

  • 14. Using buprenorphine to treat patients with opioid use disorder.
    Radi JK; Fogarty KJ; Lagerwey MD
    JAAPA; 2019 Oct; 32(10):30-35. PubMed ID: 31513035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
    Park TW; Bohnert AS; Austin KL; Saitz R; Pizer SD
    Psychiatr Serv; 2014 Jan; 65(1):4. PubMed ID: 24382761
    [No Abstract]   [Full Text] [Related]  

  • 16. Buprenorphine maintenance therapy in opioid-addicted health care professionals.
    Newman RG
    Mayo Clin Proc; 2012 Aug; 87(8):804-5; author reply 806-8. PubMed ID: 22862869
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017.
    Rhee TG; D'Onofrio G; Fiellin DA
    JAMA Netw Open; 2020 Oct; 3(10):e2021209. PubMed ID: 33079195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increases in Providers With Buprenorphine Waivers in the United States From 2016 to 2019.
    Ghertner R; Ali MM
    Psychiatr Serv; 2020 Sep; 71(9):971. PubMed ID: 32460681
    [No Abstract]   [Full Text] [Related]  

  • 19. Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice.
    Fiscella K
    Mayo Clin Proc; 2012 Aug; 87(8):806; author reply 806-8. PubMed ID: 22862872
    [No Abstract]   [Full Text] [Related]  

  • 20. A Good Place to Start - Low-Threshold Buprenorphine Initiation.
    Berk J
    N Engl J Med; 2020 Aug; 383(8):701-703. PubMed ID: 32813944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.